AFP and liver cancer: (18) found that the proportion of cirrhosis and patients in Barcelona Clinic Liver Cancer (BCLC) stages B and C was significantly higher in the AFP-positive group compared to the AFP-negative group, suggesting that AFP-positive patients have a poorer hepatic background.